International journal of radiation oncology, biology, physics
-
Int. J. Radiat. Oncol. Biol. Phys. · Feb 1995
Randomized Controlled Trial Clinical TrialInterdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
Sequencing and timing of chemotherapy and radiotherapy for limited small-cell lung cancer (LSCLC) was studied in two consecutive trials. ⋯ Concurrent chemoradiotherapy appears to be more effective than IDG. Earlier administration of PCI with concurrent chemotherapy and thoracic irradiation may reduce the risk of brain metastasis.
-
Int. J. Radiat. Oncol. Biol. Phys. · Feb 1995
Clinical TrialMethod of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer.
This article describes our technique of localization and implantation of the lumpectomy site of patients with T1 and T2 breast cancer. Our method was developed as part of our Phase I/II pilot study of high dose rate (HDR) brachytherapy alone after conservative surgery for early breast cancer. ⋯ This technique is an accurate way to localize the lumpectomy site for HDR brachytherapy.
-
Int. J. Radiat. Oncol. Biol. Phys. · Feb 1995
Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix.
To examine the incidence of radiation-induced late rectal complications using a rectal reference point in patients with cancer of the uterine cervix. ⋯ These data regarding the incidence of rectal complication may be useful in reducing the incidence of late rectal complications arising after HDR-ICR treatment of cervical uterine cancer by adjusting the dose per fraction and number of fractions of HDR-ICR in individual patients and by improving the technique of inserting the intracavitary radiation apparatus.
-
Int. J. Radiat. Oncol. Biol. Phys. · Feb 1995
Breast conservation treatment of early stage breast cancer: patterns of failure.
This study retrospectively assesses the patterns of failure in conservatively treated early stage breast cancer patients by correlating various clinical, pathologic, and treated-related factors with local, axillary, and distant relapse. ⋯ Tumors with extensive intraductal component, age under 40 years, and the omission of adjuvant tamoxifen in postmenopausal women increased local recurrence rate. Stage T2 and the lack of axillary dissection increased axillary recurrence rate. Stage N+ and local or axillary relapse increased distant failure rate. Axillary irradiation did not influence locoregional control nor survival. Improved therapy is needed for relapsing patients.
-
Int. J. Radiat. Oncol. Biol. Phys. · Feb 1995
Comparative StudyHigh dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
There is no consensus as to the best dose-fractionation regimen in high dose rate (HDR) brachytherapy for cervix cancer. Since 1983, two fractionation regimens have been used in different time periods at National Cancer Center Hospital, and their treatment results have been compared in terms of 5-year survival, local control, and complication rate to find the better therapeutic regimen. ⋯ The once-weekly HDR intracavitary applications combined with properly adjusted external beam pelvic irradiation is a safe and effective treatment for patients with uterine cervix cancer.